Colchicine for large pericardial effusion.
On the basis of our reported experience with colchicine for recurrent pericarditis, we administered colchicine to two patients with large pericardial effusions complicating idiopathic pericarditis. The first was a 26-year-old male who showed clinical deterioration following emergency pericardiocentesis and aspirin (3 g/day) for 10 days; the second was a 2-year-old girl who was unsuccessfully treated with aspirin (100 mg/kg/day) for 2 weeks, followed by corticosteroids for 7 months. Administration of colchicine (1 mg/day) instead of aspirin in the first case, and with a rapid tapering-off of the corticosteroids in the second case, led to complete regression of the pericardial effusion on echocardiography within 1 week and 1 month, respectively. Colchicine was discontinued after 1 month in the first patient and was continued for 6 months in the child. Neither has had a recurrence at 24 and 6 months of follow-up, respectively. No side effects of colchicine were observed. We conclude that colchicine may be effective in the treatment of large pericardial effusion when therapy with nonsteroidal anti-inflammatory drugs and/or corticosteroids fails.
Adler
Y
Y
Department of Cardiology, Rabin Medical Center, Beilinson Campus, Petah Tiqva, Israel.
Guindo
J
J
Finkelstein
Y
Y
Khouri
A
A
Assali
A
A
Bayes-Genis
A
A
Bayes de Luna
A
A
D000328:Adult; D002675:Child, Preschool; D002908:Chronic Disease; D003078:Colchicine / Q000627:therapeutic use*; D004452:Echocardiography; D005260:Female; D005500:Follow-Up Studies; D006074:Gout Suppressants / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D010490:Pericardial Effusion / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000209:etiology; D010493:Pericarditis / Q000150:complications; D012008:Recurrence
D006074:Gout Suppressants; D003078:Colchicine